Clinical Trials
73 trialsPOSEIDON
Centre Antoine Lacassagne
STEMRI
Institut Claudius Regaud
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
NaviFUS Corporation
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
Waikato Hospital
EF-32
NovoCure Ltd.
GLAD
Wake Forest University Health Sciences
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
INDYGO
University Hospital, Lille
SupraGlio-AI
Hospital del Rio Hortega
EVA DOPA
Centre Hospitalier Universitaire de Nīmes
FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
PROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
InSightec
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
SonoClear AS
GLIORAD
Azienda USL Reggio Emilia - IRCCS
RegoRec
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RF2019-1236878
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
University of Alabama at Birmingham
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
Clinical Laserthermia Systems AB
MMH
University Hospital Muenster
UNITED
Sunnybrook Health Sciences Centre
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
University of Texas Southwestern Medical Center
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
M.D. Anderson Cancer Center
Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
University of Cincinnati
CT Perfusion in the Prognostication of Cerebral High Grade Glioma
Nova Scotia Health Authority
Glioblastoma Psychosocial Support Program
Duke University
Evaluating Therapeutic Response to Novo-TTF
Abramson Cancer Center at Penn Medicine
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center
ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
InSightec
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
InSightec
Mathematical Model-Adapted Radiation In Glioblastoma
Dana-Farber Cancer Institute
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
National Institutes of Health Clinical Center (CC)
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
Medical University of Warsaw
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
Mayo Clinic
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Nativis, Inc.
NAT109
Nativis, Inc.
3D Printed Mask for GBM and Brain Mets
University Health Network, Toronto
EMITT
Radboud University Medical Center
Exercise in Patients With Glioblastoma
University Health Network, Toronto
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
OHSU Knight Cancer Institute
GLIOSUPPORT
Institut du Cancer de Montpellier - Val d'Aurelle
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
University Hospital Tuebingen
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
ERGO2
Johann Wolfgang Goethe University Hospital
dualFETboost
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
Karolinska Institutet
Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Massachusetts General Hospital
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Jonsson Comprehensive Cancer Center